Alpha-crystallin A chain (CRYAA) (CRYAA)

Alpha-crystallin A chain (CRYAA) is a major structural protein of the mammalian eye lens and a member of the small heat shock protein (sHSP) family (UniProt P02489). It functions primarily as a molecular chaperone, preventing the precipitation of denatured proteins and maintaining lens transparency by inhibiting the aggregation of other crystallins (PubMed: 26200341). Mutations or post-translational modifications in CRYAA are strongly linked to the development of congenital and age-related cataracts (NIH: Gene ID 1409). Beyond the lens, it exhibits anti-apoptotic properties and is being investigated for its role in neuroprotection and diabetic retinopathy (PubMed: 28463240). Therapeutic strategies often focus on small molecules like lanosterol or sterol derivatives that can stabilize the protein or restore its chaperone activity to reverse or prevent protein aggregation (Nature: 523, 607–611).

Other names

CRYAACRYA1HSPB4Heat shock protein beta-4Alpha-A-crystallin

Acts as a molecular chaperone to prevent the aggregation of misfolded proteins and maintains the solubility of lens crystallins, thereby preserving optical clarity (PubMed: 26200341).